Evidence mapPaperPMID 11225659Full record

ArticleDiabetes, obesity & metabolism2000

Effect of four-week metformin treatment on plasma and erythrocyte antioxidative defense enzymes in newly diagnosed obese patients with type 2 diabetes.

D Pavlović, R Kocić, G Kocić, T Jevtović, S Radenković, D Mikić, M Stojanović, P B Djordjević

Registry-linked trialAbstract read
PubMed Publisher
In one paragraph

Article in Diabetes, obesity & metabolism, 2000. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT04943692 (Efficacy and Safety of Metformin Glycinate Compared to Metformin Hydrochloride on the Progression of Type 2 Diabetes), which is not on this map. Cited by 21 papers.

0numbers the graph read from it
0cells of the map it votes in
21citing papers in PubMed
3.1field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT04943692 phase3suspendedstarted 2021, after this paper: background citation

Efficacy and Safety of Metformin Glycinate Compared to Metformin Hydrochloride on the Progression of Type 2 Diabetes

Ran2021Enrolled500Registered outcomes13Posted comparisons0ConditionsType 2 DiabetesArmsMetformin glycinate, Metformin hydrochloride
Open the trial in the graph
3 · Its place in the literature

Who cites it

21 citing papers in PubMed, 111 citations in OpenAlex.

  1. Trial
  2. Review
  3. Article
  4. Review
  5. Review
  6. Review
  7. Review
  8. Article
  9. Article
  10. Article
  11. Review
  12. Article
  13. Review
  14. Nrf2 and redox status in prediabetic and diabetic patients.International journal of molecular sciences · 2014
    Article
  15. Article
  16. Metformin ameliorates methotrexate-induced hepatotoxicity.Journal of pharmacology & pharmacotherapeutics · 2012
    Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 2 institutions in 2 countries.

D PavlovićBiochemistry Institute, Medical Faculty of Ni , Yugoslavia. pavlovicd@bankerinter.net
R Kocić
G Kocić
T Jevtović
S Radenković
D Mikić
M Stojanović
P B Djordjević
Institute of Biochemistry · ROUniversity of Nis · RS

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The principal metabolic effect of metformin-an oral antihyperglycaemic agent-is the improvement in the sensitivity of peripheral tissues and liver to insulin. This study examined the effect of metformin monotherapy on antioxidative defence system activity in erythrocytes and plasma in diabetic patients. We studied the effect of metformin treatment on the activities of Cu, Zn-superoxide dismutase (EC 1. 15. 1. 1.), catalase (EC 1. 11. 1. 6.) and glutathione peroxidase (EC 1. 11. 1. 9.) in relation to lipid peroxidation products and reduced glutathione level in plasma and erythrocytes. In this study we also examined erythrocytes' susceptibility to H2O2-induced oxidative stress during metformin therapy. Although metformin monotherapy ameliorated the imbalance between free radical-induced increase in lipid peroxidation (by reducing the MDA level in both erythrocytes and plasma) and decreased plasma and cellular antioxidant defences (by increasing the erythrocyte activities of Cu, Zn, SOD, catalase and GSH level) and decreased erythrocyte susceptibility to oxidative stress, it had negligible effect to scavenge Fe ion-induced free radical generation in a phospholipid-liposome system.

Indexed as

ObesityBlood GlucoseCatalaseC-PeptideDiabetes MellitusDiabetes Mellitus, Type 2ErythrocytesFructosamineGlutathioneGlutathione PeroxidaseHumansHydrogen PeroxideHypoglycemic AgentsIn Vitro TechniquesLipid PeroxidationMetforminBlood GlucoseCatalaseC-PeptideFructosamineGlutathioneGlutathione PeroxidaseHydrogen PeroxideHypoglycemic AgentsMetforminSuperoxide Dismutase

Identifiers

PMID11225659
OpenAlexW2085449229

What Socratic holds

Texttitle and abstract
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.